Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

Ireland Trends & Statistics

EMARKETER offers market research, trends and statistics for a variety of topics and industries. Here you will find a collection of reports, articles and other resources for Ireland

TikTok non-US revenues surge 38% despite headwinds

Article
Aug 25, 2025

TikTok’s 2024 revenues in the UK, Europe, and Latin America surged 38% to $6.3 billion, more than doubling 2022 levels, per filings cited by Forbes. The growth underscores TikTok’s strength outside the US, where a divest-or-ban standoff continues. Yet regulatory scrutiny in Europe looms large, with over $1 billion reserved for fines, ongoing probes across multiple countries, and potential penalties under the EU’s Digital Services Act. TikTok’s UK penetration tops 32%, with ad revenues projected to triple by 2027. Still, layoffs in trust and safety roles and a pivot to AI moderation could test regulators and user trust.

Drugs coming from the EU will face a 15% tariff

Article
Jul 29, 2025

The news: The trade deal between the US and EU will include a 15% tariff on pharmaceuticals imported from Europe, the White House said. The final word: Pharma companies and industry trade groups had been holding out hope that their medicines imported to the US would be exempt from tariffs. Not getting that reprieve is a setback—but the 15% rate on its own could be seen as a decent outcome, particularly considering that 200% tariffs were threatened and the Section 232 investigation could lead to a higher levy in other countries.

Pharma imports fell back to normal level amid stalled industry tariff threats

Article
Jun 06, 2025

The news: US pharma imports returned to normal in April after a March stockpiling of drugs and medical products spurred by tariff threats from the Trump administration. The takeaway: Fluctuating tariff threats from the Trump administration means ongoing uncertainty for drugmakers. If the indecision lags for more than a few months, expect some pharma product stockpiling to return.

FAQ: US-EU Trade War

FAQ: US-EU Trade War

Report
May 16, 2025

A trade war between two of the world’s largest consumer markets would cause significant disruption for consumers, retailers, and brands in Europe.

Wayfair says auf wiedersehen to Germany

Wayfair says auf wiedersehen to Germany

Article
Jan 13, 2025

Wayfair pivots from Germany to focus on physical retail: The country’s challenging economic climate is one reason the retailer is reallocating resources to areas with better long-term potential.

Powerful data and analysis on nearly every digital topic.

Become a Client

Want more marketing insights?

Sign up for EMARKETER Daily, our free newsletter.

By clicking "Sign Up", you agree to receive emails from EMARKETER (e.g. FYIs, partner content, webinars, and other offers) and accept our Terms of Service and Privacy Policy. You can opt-out at any time.

Thanks for signing up for our newsletter!

You can read recent articles from EMARKETER here.
Already have a subscription?Sign In
Access All Charts and Data
  • Learn about what technologies are transforming your industry
  • Gain exclusive perspectives from top industry leaders
  • Access thousands of data sets and forecasts via our iconic charts
Become a Client
or